Dillon Reid counsels clients on corporate and securities issues including mergers and acquisitions, capital markets transactions, and securities regulations matters and filings. He works within a range of industries, including healthcare, private equity, information technology, entertainment and others.
Prior to joining Bass, Berry & Sims, Dillon was an associate at Cahill Gordon & Reindel LLP in New York. Dillon earned his law degree from the Cornell Law School and a Bachelor of Arts and Science in psychology from the University of Tennessee.
American Health Law Association (AHLA)
Representation of Forcura, LLC, a healthcare technology that facilitates continuity of care, in its sale to Accel-KKR, a Silicon Valley-based technology-focused private equity firm
Served as regulatory and deal counsel to BioPlus, a leading national specialty pharmacy, and ProHealth Pharmacy Solutions, a significant provider of infusion pharmacy management services in their sale to CarepathRx a platform company formed by Nautic Partners
Representation of i3 Verticals, Inc. (Nasdaq: IIIV), an integrated payment and software solutions provider, in its offering of $138 million aggregate principal amount of 1.00% Exchangeable Senior Notes due 2025, its concurrent amendment to its Amended and Restated Credit Agreement, and its concurrent entrance into exchangeable note hedge and warrant transactions with certain financial institutions. BofA Securities served as the representative of the initial purchasers of the exchangeable notes
Representation of HCA Healthcare (NYSE: HCA), one of the nation’s leading healthcare providers, in its acquisition of Valify, a healthcare cost management technology platform
Representation of Tennessee Community Bank Holdings, Inc., the parent company for Community Bank & Trust located in Ashland City, Tennessee, in its definitive agreement to sell to Reliant Bancorp, Inc. (Nasdaq: RBNC) for $37 million in an approximately 50% stock and 50% cash transaction.
Representation of i3 Verticals, Inc. (Nasdaq: IIIV), an integrated payment and software solutions provider, in its secondary offering of 5,165,527 shares of Class A common stock at $22.75 per share. The underwriters included Cowen, Raymond James and BofA Merrill Lynch
International Law Journal — Managing Editor